Vaccinia virus intermediate and late promoter elements are targeted by the TATA-binding protein

Journal of Virology

Volumn 80, Issue 14, 2006, Pages 6784-6793

  Knutson, Bruce A ^a   Liu, Xu ^a,b   Oh, Jaewook ^a,c   Broyles, Steven S ^a  

^a PURDUE UNIVERSITY   (United States)

^b United States Patent and Trademark Office   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

E1A PROTEIN; MUTANT PROTEIN; NUCLEOTIDE; RNA POLYMERASE; TATA BINDING PROTEIN; TRANSCRIPTION FACTOR;

ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; CYTOPLASM; GENE TARGETING; GENETIC TRANSCRIPTION; HOST CELL; HUMAN; HUMAN CELL; NONHUMAN; POXVIRUS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN MOTIF; RNA INTERFERENCE; TATA BOX; VACCINIA VIRUS; VIRUS CELL INTERACTION; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

ADENOVIRUS E1A PROTEINS; DNA, VIRAL; DNA-DIRECTED RNA POLYMERASES; GENE EXPRESSION REGULATION, VIRAL; GENES, DOMINANT; HELA CELLS; HUMANS; MODELS, BIOLOGICAL; MUTATION; RESPONSE ELEMENTS; RNA INTERFERENCE; TATA-BOX BINDING PROTEIN; TRANSCRIPTION, GENETIC; VACCINIA VIRUS; VIRUS REPLICATION;

ADENOVIRIDAE; POXVIRIDAE; VACCINIA VIRUS;

EID: 33745790463     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02705-05     Document Type: Article

References (42)

1. Abu-Daya, A., P. M. Brown, and K. R. Fox. 1995. DNA sequence specificity of several A-T-selective minor groove binding ligands. Nucleic Acids Res. 23:3385-3392.
2. Baldick, C. J., Jr., J. G. Keck, and B. Moss. 1992. Mutational analysis of the core, spacer, and initiator regions of vaccinia virus intermediate-class promoters. J. Virol. 66:4710-4719.
3. Boyd, J. M., P. M. Loewenstein, Q. Tang, L. Yu, and M. Green. 2002. Adenovirus E1A N-terminal amino acid sequence requirements for repression of transcription in vitro and in vivo correlate with those required for E1A interference with TBP-TATA complex formation. J. Virol. 76:1461-1474.
4. Broyles, S. S. 2003. Vaccinia virus transcription. J. Gen. Virol. 84:2293-2303.
5. Broyles, S. S., M. Kremer, and B. A. Knutson. 2004. Antiviral activity of distamycin A against vaccinia virus is the result of inhibition of postreplicative mRNA synthesis. J. Virol. 78:2137-2141.
6. Broyles, S. S., X. Liu, M. Zhu, and M. Kremer. 1999. Transcription factor YY1 is a vaccinia virus late promoter activator. J. Biol. Chem. 274:35662-35667.
7. Burley, S. K., and R. G. Roeder. 1996. Biochemistry and structural biology of transcription factor IID (TFIID). Annu. Rev. Biochem. 65:769-799.
8. Chiang, S.-Y., J. Welch, F. J. Rauscher III, and T. A. Beerman. 1994. Effects of minor groove binding drugs on the interaction of TATA box binding protein and TFIIA with DNA. Biochemistry 33:7033-7040.
9. Davidson, I. 2003. The genetics of TBP and TBP-related factors. Trends Biochem. Sci. 28:391-398.
10. Davison, A. J., and B. Moss. 1989. Structure of vaccinia virus late promoters. J. Mol. Biol. 210:771-784.
11. Fuerst, T. R., E. G. Niles, F. W. Studier, and B. Moss. 1986. Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc. Natl. Acad. Sci. USA 83:8122-8126.
12. Garvie, C. W., and C. Wolberger. 2001. Recognition of specific DNA sequences. Mol. Cell 8:937-946.
13. Hanggi, M., W. Bannwarth, and H. G. Stunnenberg. 1986. Conserved TAAAT motif in vaccinia virus late promoters: overlapping TATA box and site of transcription initiation. EMBO J. 5:1071-1076.
14. Hoopes, B. C., J. F. LeBlanc, and D. K. Hawley. 1998. Contributions of the TATA box sequence to rate-limiting steps in transcription initiation by RNA polymerase II. J. Mol. Biol. 277:1015-1031.
15. Katsafanas, G. C., and B. Moss. 2004. Vaccinia virus intermediate stage transcription is complemented by Ras-GTPase-activating protein SH3 domain-binding protein (G3BP) and cytoplasmic activation/proliferation- associated protein (p137) individually or as a heterodimer. J. Biol. Chem. 279: 52210-52217.
16. Keck, J. G., C. J. Baldick, Jr., and B. Moss. 1990. Role of DNA replication in vaccinia virus gene expression: a naked template is required for transcription of three late trans-activator genes. Cell 61:801-809.
17. Kim, J. L., D. B. Nikolov, and S. K. Burley. 1993. Co-crystal structure of TBP recognizing the minor groove of a TATA element. Nature 365:520-527.
18. Kim, Y., J. H. Geiger, S. Hahn, and P. Sigler. 1993. Crystal structure of a yeast TBP/TATA-box complex. Nature 365:512-520.
19. Leirdall, M., and M. Sioud. 2002. Gene silencing in mammalian cells by preformed small RNA duplexes. Biochem. Biophys. Res. Commun. 295:744-748.
20. Liu, X., M. Kremer, and S. S. Broyles. 2004. A natural vaccinia virus promoter with exceptional capacity to direct protein synthesis. J. Virol. Methods 122:141-145.
21. Lown, J. W., K. Krowicki, J. Balzarini, R. A. Newman, and E. De Clercq. 1989. Novel linked antiviral and antitumor agents related to netropsin and distamycin: synthesis and biological evaluation. J. Med. Chem. 32:2368-2375.
22. Miller, J. H. 1972. Experiments in molecular genetics, p. 352-355. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
23. Moss, B. 2001. Poxviruses and their replication, p. 2849-2884. In D. M. Knipe and P. M. Howley (ed.), Fields virology, 4th ed. Lippincott, Williams, and Wilkins, Philadelphia, Pa.
24. Oh, J., and S. S. Broyles. 2005. Host cell nuclear proteins are recruited to cytoplasmic vaccinia virus replication complexes. J. Virol. 79:12852-12860.
25. Pugh, B. F. 2000. Control of gene expression through regulation of the TATA-binding protein. Gene 255:1-14.
26. Rasti, M., R. J. Grand, J. S. Mymryk, P. H. Gallimore, and A. S. Turnell. 2005. Recruitment of CBP/p300, TATA-binding protein, and S8 to distinct regions at the N terminus of adenovirus E1A. J. Virol. 79:5594-5605.
27. Reddy, P., and S. Hahn. 1991. Dominant negative mutations in yeast TFIID define a bipartite DNA-binding domain. Cell 65:349-357.
28. Rosales, R., N. Harris, B. Y. Ahn, and B. Moss. 1994. Purification and identification of a vaccinia virus-encoded intermediate stage promoter-specific transcription factor that has homology to eukaryotic transcription factor SII (TFIIS) and an additional role as a viral RNA polymerase subunit. J. Biol. Chem. 269:14260-14267.
29. Rosales, R., G. Sutter, and B. Moss. 1994. A cellular factor is required for transcription of vaccinia viral intermediate-stage genes. Proc. Natl. Acad. Sci. USA 91:3794-3798.
30. Sanz, P., and B. Moss. 1999. Identification of a transcription factor, encoded by two vaccinia virus early genes, that regulates the intermediate stage of viral gene expression. Proc. Natl. Acad. Sci. USA 96:2692-2697.
31. Schmitt, J. F., and H. G. Stunnenberg. 1988. Sequence and transcriptional analysis of the vaccinia virus HindIII I fragment. J. Virol. 62:1889-1897.
32. Song, C. Z., P. M. Loewenstein, K. Toth, and M. Green. 1995. Transcription factor TFIID is a direct functional target of the adenovirus E1A transcription-repression domain. Proc. Nat. Acad. USA 92:10330-10333.
33. Song, C. Z., P. M. Loewenstein, K. Toth, Q. Tang, A. Nishikawa, and M. Green. 1997. The adenovirus E1A repression domain disrupts the interaction between the TATA binding protein and the TATA box in a manner reversible by TFIIB. Mol. Cell. Biol. 17:2186-2193.
34. Starr, D. B., and D. K. Hawley. 1991. TFIID binds in the minor groove of the TATA box. Cell 67:1231-1240.
35. Strauss, D., O. Elroy-Stein, and R. Ehrlich. 1997. Adenovirus E1A interferes with expression of vaccinia viral genes. Gene 184:279-284.
36. Tyagi, R., R. Lai, and R. G. Duggleby. 2004. A new approach to 'megaprimer' polymerase chain reaction mutagenesis without an intermediate gel purification step. BMC Biotechnol. 4:2.
37. Vanathi, P., A. K. Mishra, and P. Bharagava. 2003. Regulation of actvity of the yeast TATA-binding protein through intra-molecular interactions. J. Biosci. 28:313-421.
38. Van Etten, J. L. 2003. Unusual life style of giant Chlorella viruses. Annu. Rev. Genet. 37:153-159.
39. Verini, M. A., and M. Ghione. 1964. Activity of distamycin A on vaccinia infection in culture. Chemotherapy 9:144-157.
40. Veschambre, P., P. Simard, and P. Jalinot. 1995. Evidence for functional interaction between the HIV-1 Tat transactivator and the TATA box binding protein in vivo. J. Mol. Biol. 250:169-180.
41. Vos, J. C., M. Sasker, and H. G. Stunnenberg. 1991. Vaccinia virus capping enzyme is a transcription initiation factor. EMBO J. 10:2553-2558.
42. Wright, C. F., B. W. Oswald, and S. Dellis. 2001. Vaccinia virus late transcription is activated in vitro by cellular heterogeneous nuclear ribonucleoproteins. J. Biol. Chem. 276:40680-40686.